Invention Grant
- Patent Title: Triazolo-pyridine compound
- Patent Title (中): 三唑并吡啶化合物
-
Application No.: US14559956Application Date: 2014-12-04
-
Publication No.: US09120793B2Publication Date: 2015-09-01
- Inventor: Chafiq Hamdouchi
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent MaCharri Vorndran-Jones
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/437 ; C07D471/04
Abstract:
The present invention provides compounds of the formula wherein R1 is selected from the group consisting of H and CH3; R2 is selected from the group consisting of H and CH3; R3 is selected from the group consisting of H, C1-C3 alkyl, O(CH2)3SO2CH3, O(CH2)2OCH3, O(CH2)2C(CH3)2OH, CN, and OCF2; or a pharmaceutical salt thereof, methods of treating diabetes, intermediates, and a process for preparing compounds of the invention.
Public/Granted literature
- US20150166535A1 NOVELTRIAZOLO-PYRIDINE COMPOUND Public/Granted day:2015-06-18
Information query
